Two components of delayed rectifier K+ current in heart: Molecular basis, functional diversity, and contribution to repolarization

Acta Pharmacologica Sinica

Volumn 25, Issue 2, 2004, Pages 137-145

  Cheng, Jian Hua ^a   Kodama, Itsuo ^b  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b NAGOYA UNIVERSITY   (Japan)

Author keywords

Action potentials; Anti arrhythmia agents; Beta adrenergic receptors; Long QT syndrome; Potassium channels

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; MEMBRANE PROTEIN; MIRP1 PROTEIN; POTASSIUM CHANNEL; POTASSIUM CHANNEL HERG; POTASSIUM CHANNEL KCNQ1; UNCLASSIFIED DRUG;

ACTION POTENTIAL; BETA ADRENERGIC STIMULATION; CHANNEL GATING; EPICARDIUM; GENE MUTATION; HEART DEPOLARIZATION; HEART MUSCLE ISCHEMIA; HEART RATE; HEART REPOLARIZATION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAMMAL; NONHUMAN; POTASSIUM CHANNEL KCNE1; POTASSIUM CHANNEL KCNE2; POTASSIUM CURRENT; PROTEIN PROTEIN INTERACTION; QT PROLONGATION; REVIEW; RISK FACTOR; TORSADE DES POINTES;

ACTION POTENTIALS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; DELAYED RECTIFIER POTASSIUM CHANNELS; HUMANS; LONG QT SYNDROME; POTASSIUM CHANNELS; POTASSIUM CHANNELS, VOLTAGE-GATED; RECEPTORS, ADRENERGIC, BETA; SPECIES SPECIFICITY;

EID: 0442278007     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. + current: differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol 1990; 96: 195-215.
2. Ks in dog ventricular muscle and Purkinje fiber repolarization. J Physiol 2000; 523: 67-81.
3. + current: a potential mechanism of the proarrhythmic effects of methanesulfonanilide class III agents. Cardiovasc Res 1999; 43: 135-47.
4. Roden DM, Balser JR, George Jr AL, Anderson ME. Cardiac ion channels. Annu Rev Physiol 2002; 64: 431-75.
5. Virag L, Iost N, Opincariu M, Szolnoky J, Szecsi J, Bogats G, et al. The slow component of the delayed rectifier potassium current in undiseased human ventricular myocytes. Cardiovasc Res 2001; 49: 790-7.
6. Iost N, Virag L, Opincariu M, Szecsi J, Varro A, Papp JG. Delayed rectifier potassium current in undiseased human ventricular myocytes. Cardiovasc Res 1998; 40: 508-15.
7. Xu X, Rials SJ, Wu Y, Salata JJ, Liu T, Bharucha DB, et al. Left ventricular hypertrophy decreases slowly but not rapidly activating delayed rectifier potassium currents of epicardial and endocardial myocytes in rabbits. Circulation 2001; 103: 1585-90.
8. Ks) fails to lengthen rabbit ventricular muscle QTc and action potential duration. Br J Pharmacol 2001; 132: 101-10.
9. Ks blockade at high heart rate in guinea pig and rabbit: implications for arrhythmogenesis in humans. Circulation 2001; 104: 951-6.
10. Ks play a role in the reverse rate dependence of class III agents? Circ Res 1996; 78: 26-37.
11. Furukawa T, Kimura S, Furukawa N, Bassett AL, Myerburg RJ. Potassium rectifier currents differ in myocytes of endocardial and epicardial origin. Circ Res 1992; 70: 91-103.
12. Ks contributes to the longer action potential of the M cell. Circ Res 1995; 76: 351-65.
13. Ks) contribute to the differences in action potential duration in basal left ventricular myocytes in guinea-pig. Cardiovasc Res 1998; 40: 322-31.
14. Anyukhovsky EP, Sosunov EA, Rosen MR. Regional differences in electrophysiological properties of epicardium, midmyocardium, and endocardium: in vitro and in vivo correlations. Circulation 1996; 94: 1981-8.
15. Ks-blocking agent chromanol 293b on individual muscle layers of the intact canine heart. Circulation 1999; 100: 2184-90.
16. Ks-blocking agent chromanol 293b on regional disparity of left ventricular repolarization in the intact canine heart. J Cardiovasc Pharmacol 2002; 39: 460-7.
17. Iwata H, Kodama I, Suzuki R, Kamiya K, Toyama J. Effects of long-term oral administration of amiodarone on the ventricular repolarization of rabbit hearts. Jpn Circ J 1996; 60: 662-72.
18. + current in the ferret heart. Circ Res 1997; 81: 128-35.
19. + currents in dogs with chronic complete atrioventricular block and acquired torsades de pointes. Circulation 1999; 100: 2455-61.
20. Kr potassium channel. Cell 1995; 81: 299-307.
21. Trudeau MC, Warmke JW, Ganetzky B, Robertson GA. HERG, a human inward rectifier in the voltage-gated potassium channel family. Science 1995; 269: 92-5.
22. Kr. Nature 1997; 388: 289-92.
23. Kr potassium channels with HERG and is associated with cardiac arrhythmia. Cell 1999; 97: 175-87.
24. + currents by an antisense oligodeoxynucleotide against IsK (minK) and over-expression of IsK mutant D77N in neonatal mouse hearts. Pflügers Arch 2001; 442: 329-35.
25. Weerapura M, Nattel S, Chartier D, Caballero R, Hebert TE. A comparison of currents carried by HERG, with and without coexpression of MiRP1, and the native rapid delayed rectifier current. Is MiRP1 the missing link? J Physiol 2002; 540: 15-27.
26. + current. Circ Res 1997; 81: 870-8.
27. + channel in mouse and human hearts. Circ Res 1997; 81: 719-26.
28. + channel splice variant common in human heart lacks a C-terminal domain required for expression of rapidly activating delayed rectifier current. J Biol Chem 1998; 273: 27231-5.
29. Sanguinetti MC, Curran ME, Zou A, Shen J, Spector PS, Atkinson DL, et al. Coassembly of KvLQT1 and minK (IsK) proteins to form cardiac IKs potassium channel. Nature 1996; 384: 81-3.
30. Ks cardiac potassium current. Nature 1996; 384: 78-80.
31. Demolombe, S, Baró I, Péréon Y, Bliek J, Mohammad-Panah R, Pollard H, et al. A dominant negative isoform of the long QT syndrome 1 gene product. J Biol Chem 1998; 273: 6837-43.
32. Péréon Y, Demolombe S, Baró I, Drouin E, Charpentier F, Escande D. Differential expression of KvLQT1 isoforms across the human ventricular wall. Am J Physiol Heart Circ Physiol 2000; 278: H1908-H15.
33. Drouin E, Charpentier F, Gauthier C, Laurent K, Le Marec H. Electrophysiologic characteristics of cells spanning the left ventricular wall of human heart: evidence for presence of M cells. J Am Coll Cardiol 1995; 26: 185-92.
34. Sanguinetti MC. Dysfunction of delayed rectifier potassium channels in an inherited cardiac arrhythmia. Ann N Y Acad Sci 1999; 868: 406-13.
35. Priori SG, Napolitano C, Schwartz PJ. Low penetrance in the long-QT syndrome: clinical impact. Circulation 1999; 99: 529-33.
36. Swan H, Saarinen K, Kontula K, Toivonen L, Viitasalo M. Evaluation of QT interval duration and dispersion and proposed clinical criteria in diagnosis of long QT syndrome in patients with a genetically uniform type of LQT1. J Am Coll Cardiol 1998; 32: 486-91.
37. Sanguinetti MC, Jurkiewicz NK, Scott A, Siegl PK. Isoproterenol antagonizes prolongation of refractory period by the class III antiarrhythmic agent E-4031 in guinea pig myocytes. Mechanism of action. Circ Res 1991; 68: 77-84.
38. Han W, Wang Z, Nattel S. Slow delayed rectifier current and repolarization in canine cardiac Purkinje cells. Am J Physiol Heart Circ Physiol 2001; 280: H1075-80.
39. Potet F, Scott JD, Mohammad-Panah R, Escande D, Baro I. AKAP proteins anchor cAMP-dependent protein kinase to KvLQT1/IsK channel complex. Am J Physiol Heart Circ Physiol 2001; 280: H2038-45.
40. Marx SO, Kurokawa J, Reiken S, Motoike H, D'Armiento J, Marks AR, et al. Requirement of a macromolecular signaling complex for β-adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science 2002; 295: 496-9.
41. Warmke JW, Ganetzky B. A family of potassium channel genes related to eag in drosophila and mammals. Proc Natl Acad Sci USA 1994; 91: 3438-42.
42. 1-adrenoreceptor activation, via cAMP/protein kinase A-dependent pathways. Cardiovasc Res 2002; 53: 355-62.
43. + channel by dual pathways. Curr Biol 2000; 10: 671-4.
44. Ks) components of the delayed rectifier potassium current is associated with additional drug effects on lengthening of cardiac repolarization. J Cardiovasc Pharmacol Ther 1999; 4: 143-150.
45. Roden DM. Ionic mechanisms for prolongation of refractoriness and their proarrhythmic and antiarrhythmic correlates. Am J Cardiol 1996; 72: 12-6.
46. Nair LA, Grant AO. Emerging class III antiarrhythmic agents: mechanism of action and proarrhythmic potential. Cardiovasc Drugs Ther 1997; 11: 149-67.
47. Schreieck J, Wang Y, Gjini V, Korth M, Zrenner B, Schomig A, et al. Differential effect of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of the new class III antiarrhythmics dofetilide, ambasilide, and chromanol 293B. J Cardiovasc Electrophysiol 1997; 8: 1420-30.
48. Ks does not induce early afterdepolarization activity but promotes β-adrenergic agonist-induced delayed afterdepolarization activity. J Cardiovasc Electrophysiol 2000; 11: 458-65.
49. Ks, in canine models of malignant ischemic ventricular arrhythmia. Circulation 1999; 100: 1917-22.
50. Ks and β-adrenergic receptor blockade. J Pharmacol Exp Ther 2002; 302: 283-9.
51. + currents have reduced amplitudes and altered kinetics in myocytes from infarcted canine ventricle. Cardiovasc Res 2000; 48: 34-43.
52. Tsuji Y, Opthof T, Kamiya K, Yasui K, Liu W, Lu Z, et al. Pacing-induced heart failure causes a reduction of delayed rectifier potassium currents along with decreases in calcium and transient outward currents in rabbit ventricle. Cardiovasc Res 2000; 48: 300-9.
53. Li D, Melnyk P, Feng J, Wang Z, Petrecca K, Shrier A, et al. Effects of experimental heart failure on atrial cellular and ionic electrophysiology. Circulation 2000; 101: 2631-8.
54. Lai LP, Su MJ, Lin JL, Lin FY, Tsai CH, Chen YS, et al. Changes in the mRNA levels of delayed rectifier potassium channels in human atrial fibrillation. Cardiology 1999; 92: 248-55.
55. Vos MA, Verduyn SC, Gorgels AP, Lipcsei GC, Wellens HJ. Reproducible induction of early afterdepolarization and torsades de pointes arrhythmias by d-sotalol and pacing in dogs with chronic atrioventricular block. Circulation 1995; 91: 864-72.
56. Vos MA, de Groot SH, Verduyn SC, van der Zande J, Leunissen HD, Cleutjens JP, et al. Enhanced susceptibility for acquired torsades de pointes arrhythmias in the dog with chronic, complete AV block is related to cardiac hypertrophy and electrical remodeling. Circulation 1998; 98: 1125-35.
57. Volders PG, Sipido KR, Vos MA, Kulcsar A, Verduyn SC, Wellens HJ. Cellular basis of biventricular hypertrophy and arrhythmogenesis in dogs with chronic atriventricular block and acquired torsades de pointes. Circulation 1998; 98: 1136-47.
58. Ks are larger in right than left canine ventricular midmyocardium. Circulation 1999; 99: 206-10.
59. Tsuji Y, Opthof T, Yasui K, Inden Y, Takemura H, Niwa N, et al. Ionic mechanisms of acquired QT prolongation and torsades de pointes in rabbits with chronic complete atrioventricular block. Circulation 2002; 106: 2012-8.
60. De Ponti F, Poluzzi E, Montanaro N. Organizing evidence on QT prolongation and occurrence of torsades de pointes with non-antiarrhythmic drugs: a call for consensus. Eur J Clin Pharmacol 2001; 57: 185-209.
61. Mitcheson JS, Chen J, Lin M, Culberson C, Sanguinetti MC. A structural basis for drug-induced long QT syndrome. Proc Natl Acad Sci USA 2000; 97: 12329-33.
62. Roden DM. Pharmacogenetics and drug-induced arrhythmias. Cardiovasc Res 2001; 50: 224-31.